{"id":"W4398775198","doi":"10.1007/s40257-024-00864-1","title":"Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program","year":2024,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"National Center for Advancing Translational Sciences","keywords":"Alopecia areata; Medicine; TEC; Dermatology; Clinical trial; Pharmacotherapy; Family medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006010654,0.0009267998,0.001009858,0.001869784,0.001293963,0.00292914,0.001891615,0.004479065,0.2341166],"category_scores_gemma":[0.08102264,0.0006898725,0.001496967,0.001665127,0.001049647,0.001725318,0.001193313,0.006422422,0.07043205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003774235,"about_ca_system_score_gemma":0.006591489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01593776,"about_ca_topic_score_gemma":0.0184069,"domain_scores_codex":[0.9946796,0.0009819821,0.0007196905,0.0004844256,0.002697655,0.0004366388],"domain_scores_gemma":[0.9556067,0.01644309,0.002886707,0.001884768,0.02166179,0.001516916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003888025,0.000002989846,0.00003038524,0.0000498493,0.000004034743,0.00004211023,0.000008151011,0.0000204112,0.00002063167,0.0002154263,0.9959831,0.003583961],"study_design_scores_gemma":[0.0001291641,0.00002780501,0.0005256647,0.0003440612,0.00002264221,0.0002382853,0.00002503832,0.0001693191,0.0001758654,0.0006599826,0.9976654,0.00001675604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0008850605,0.002051911,0.005046208,0.1762633,0.7110963,0.0004596553,0.05668783,0.00472057,0.04278911],"genre_scores_gemma":[0.02615917,0.008509981,0.01626551,0.1937735,0.1870647,0.001558608,0.05821673,0.009382605,0.4990693],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.2341166,"threshold_uncertainty_score":0.7831981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1088003653101052,"score_gpt":0.4783574250397168,"score_spread":0.3695570597296116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}